Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:associated_with |
gptkb:Lynch_syndrome
endometrial cancer estrogen exposure |
| gptkbp:can_cause |
gptkb:anemia
fatigue weight loss pelvic pain |
| gptkbp:can_detect |
gptkb:MRI
CT scan hysteroscopy transvaginal ultrasound |
| gptkbp:can_lead_to |
metastasis
|
| gptkbp:characterized_by |
glandular differentiation
|
| gptkbp:death |
varies by stage
higher in early stages |
| gptkbp:diagnosis |
imaging studies
biopsy depends on stage depends on grade |
| gptkbp:genetic_studies |
gptkb:KRAS
gptkb:PTEN gptkb:PIK3_CA |
| https://www.w3.org/2000/01/rdf-schema#label |
Endometrioid carcinoma
|
| gptkbp:is_associated_with |
poor prognosis in advanced stages
|
| gptkbp:is_common_in |
gptkb:women
African American women Asian women |
| gptkbp:is_linked_to |
genetic predisposition
|
| gptkbp:is_often_involved_in |
postmenopausal women
|
| gptkbp:is_related_to |
infertility
endometrial hyperplasia |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:number_of_stages |
Stage I
Stage II Stage III Stage IV |
| gptkbp:occurs_in |
other cancers
|
| gptkbp:prevention |
healthy lifestyle
regular screenings |
| gptkbp:risk_factor |
obesity
hormonal imbalance |
| gptkbp:scientific_classification |
Type I endometrial cancer
Type II endometrial cancer |
| gptkbp:symptoms |
abnormal vaginal bleeding
|
| gptkbp:treatment |
gptkb:immunotherapy
gptkb:surgery radiation therapy chemotherapy targeted therapy hormonal therapy depends on response to therapy |
| gptkbp:type_of |
endometrial carcinoma
|
| gptkbp:bfsParent |
gptkb:Epithelial_ovarian_cancer
|
| gptkbp:bfsLayer |
6
|